ScholarIQanswers from OpenAlex
University of St.Gallen
InstitutionResearch output, impact & collaborations
University of St.Gallen is a institution indexed in ScholarIQ from OpenAlex.
What is known about University of St.Gallen?
ScholarIQrecord summary
University of St.Gallen is a research organisation in Saint Gallen, CH. OpenAlex records 27,066 works and 1,067,293 citations for it. 4,314 researchers list it as their most recent affiliation.
How many works does University of St.Gallen have?
ScholarIQindexed works
University of St.Gallen has 27,066 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does University of St.Gallen have?
ScholarIQcitation count
University of St.Gallen has 1,067,293 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at University of St.Gallen?
ScholarIQresearcher count
University of St.Gallen has 4,314 researchers in the ScholarIQ index.
What is the average h-index at University of St.Gallen?
ScholarIQavg h-index
University of St.Gallen has an average h-index of 52.5 in OpenAlex.
What is the ROR of University of St.Gallen?
ScholarIQror
The ROR for University of St.Gallen is on the source record.
What is the OpenAlex record for University of St.Gallen?
ScholarIQopenalex
The OpenAlex for University of St.Gallen is on the source record.
Who are the most-cited researchers behind University of St.Gallen?
ScholarIQtop researchers by citations
What are the most-cited papers on University of St.Gallen?
ScholarIQmost cited works
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Gϋnter von Minckwitz, Michael Untch, Jens‐Uwe Blohmer, Serban Dan Costa, Holger Eidtmann, Peter A. Fasching, Bernd Gerber, W. Eiermann, J. Hilfrich, Jens Huober, Christian Jackisch, Manfred Kaufmann, Gottfried E. Konecny, Carsten Denkert, Valentina Nekljudova, Keyur Mehta, Sibylle Loibl
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
Carsten Denkert, Gϋnter von Minckwitz, Silvia Darb‐Esfahani, Bianca Lederer, Barbara Ingold Heppner, Karsten E. Weber, Jan Budczies, Jens Huober, Frederick Klauschen, Jenny Furlanetto, Wolfgang Schmitt, Jens‐Uwe Blohmer, Thomas Karn, Berit M. Pfitzner, Sherko Kümmel, Knut Engels, Andreas Schneeweiß, Arndt Hartmann, Aurelia Noske, Peter A. Fasching, Christian Jackisch, Marion van Mackelenbergh, Hans‐Peter Sinn, Christian Schem, Claus Hanusch, Michael Untch, Sibylle Loibl
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
Giuseppe Curigliano, Harold J. Burstein, Eric P. Winer, Michael Gnant, Peter Dubsky, Sibylle Loibl, Marco Colleoni, Meredith M. Regan, Martine Piccart, Hans-Jörg Senn, Beat Thürlimann, Fabrice André, José Baselga, Jonas Bergh, Hervé Bonnefoi, Sara Y. Brucker, Fátima Cardoso, Lisa A. Carey, Eva Ciruelos, Jack Cuzick, Carsten Denkert, Angelo Di Leo, Bent Ejlertsen, Prudence A. Francis, V.E. Galimberti, Judy E. Garber, Bahadır M. Güllüoğlu, Pamela J. Goodwin, Nadia Harbeck, Daniel F. Hayes, Chiun‐Sheng Huang, Jens Huober, Hussein Khaled, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, Kent C. Osborne, Olivia Pagani, Ann H. Partridge, K. Pritchard, Jungsil Ro, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Toru Watanabe, Timothy J. Whelan, Binghe Xu
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
Gϋnter von Minckwitz, Andreas Schneeweiß, Sibylle Loibl, Christoph Salat, Carsten Denkert, Mahdi Rezai, Jens‐Uwe Blohmer, Christian Jackisch, Stefan Paepke, Bernd Gerber, Dirk M. Zahm, Sherko Kümmel, Holger Eidtmann, Peter Klare, Jens Huober, Serban Dan Costa, Hans Tesch, Claus Hanusch, J. Hilfrich, F Khandan, Peter A. Fasching, Bruno V. Sinn, Knut Engels, Keyur Mehta, Valentina Nekljudova, Michael Untch
Overcoming the Service Paradox in Manufacturing Companies
Heiko Gebauer, Elgar Fleisch, Thomas Friedli
How much of the research on University of St.Gallen is open access?
ScholarIQopen access share
33%OPEN ACCESS